4
Changes in Ownership
Altimmune, Inc. Filed Acc 0000925421-19-000135
Options or other derivatives
- Chief Scientific Officer acquired 38,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-26 | Grant or award : show line 1 in the form Stock Options (option to buy) | +38,000 | 38,000 | D |
Loading xslF345X03/edgar.xml…